CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 14, 2024 · earnings

LRMR earnings: a negative outcome, -6.6%

On March 14, 2024, Larimar Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.6% in the window around the event.

The move

$9.30
1d before
$8.69
Event day
$8.70
1d after
$8.59
5d after

Pre-catalyst setup

-1.3%
30-day run-up
15501%
30-day volatility
0.5×
volume spike